Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Mar 11:2018:9234105.
doi: 10.1155/2018/9234105. eCollection 2018.

Exercise Intervention Associated with Cognitive Improvement in Alzheimer's Disease

Meng Ying Cui  1 , Yang Lin  1 , Ji Yao Sheng  1 , Xuewen Zhang  1 , Ran Ji Cui  1
Affiliations
Review

Exercise Intervention Associated with Cognitive Improvement in Alzheimer's Disease

Meng Ying Cui et al. Neural Plast. .

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disease with the syndrome of cognitive and functional decline. Pharmacotherapy has always been in a dominant position for the treatment of AD. However, in most cases, drug therapy is accompanied with clinical delays when older adults have suffered from cognitive decline in episodic memory, working memory, and executive function. On the other hand, accumulating evidence suggests that exercise intervention may ameliorate the progression of cognitive impairment in aging ones while the standard strategy is lacking based on different levels of cognitive decline especially in mild cognitive impairment (MCI) and AD. MCI is the preclinical stage of AD in which neurodegeneration may be reversed via neuroplasticity. Therefore, taking exercise intervention in the early stage of MCI and healthy aging at the risk of AD could slow down the process of cognitive impairment and provide a promising cost-effective nonpharmacological therapy to dementia.

PubMed Disclaimer

References

    1. Murphy S. L., Xu J., Kochanek K. D. Deaths: final data for 2010. National Vital Statistics Report. 2013;61(4):1–117. - PubMed
    1. Wortmann M. Dementia: a global health priority - highlights from an ADI and World Health Organization report. Alzheimer’s Research & Therapy. 2012;4(5):p. 40. doi: 10.1186/alzrt143. - DOI - PMC - PubMed
    1. Kirova A. M., Bays R. B., Lagalwar S. Working memory and executive function decline across normal aging, mild cognitive impairment, and Alzheimer’s disease. BioMed Research International. 2015;2015:9. doi: 10.1155/2015/748212.748212 - DOI - PMC - PubMed
    1. Skaper S. D., Facci L., Zusso M., Giusti P. Synaptic plasticity, dementia and Alzheimer disease. CNS & Neurological Disorders Drug Targets. 2017;16(3):220–233. doi: 10.2174/1871527316666170113120853. - DOI - PubMed
    1. Di Santo S. G., Prinelli F., Adorni F., Caltagirone C., Musicco M. A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer’s disease. Journal of Alzheimer’s Disease. 2013;35(2):349–361. doi: 10.3233/JAD-122140. - DOI - PubMed

Publication types